User menu

Adjuvant trial in melanoma patients comparing rIFN-alpha to rIFN-gamma to Iscador to a control group after curative resection of high risk primary (>= 3MM) or regional lymphnode metastasis (EORTC 18871)

Bibliographic reference Kleeberg, UR ; Brocker, EB ; Lejeune, F. ; Chartier, C ; Egger, C ; et. al. Adjuvant trial in melanoma patients comparing rIFN-alpha to rIFN-gamma to Iscador to a control group after curative resection of high risk primary (>= 3MM) or regional lymphnode metastasis (EORTC 18871).In: European Journal of Cancer, Vol. 35, p. S82-S82 (1999)
Permanent URL http://hdl.handle.net/2078.1/62227